Out-license Agreements - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended						3 Months Ended		6 Months Ended		12 Months Ended
	Aug. 31, 2024	Jul. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Sep. 30, 2022	Oct. 31, 2021	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2022	Mar. 31, 2024
License Collaboration And Manufacturing Agreements [Line Items]
Revenue							$ 17,575	$ 28,640	$ 115,724	$ 55,997
Deferred revenue, revenue recognized									90,500
Pierre Fabre Commercialization Agreement
License Collaboration And Manufacturing Agreements [Line Items]
Upfront cash payment received			$ 20,000			$ 45,000
Milestone payments				$ 40,000							$ 40,000	$ 20,000
Additional milestone payments		$ 20,000							40,000
Royalty eligible to receive term after first commercial sale			12 years			12 years
Payments received from sale of inventory	$ 15,500
Determined upfront payment constituted entire consideration included in transaction price						$ 45,000
Development or sales-based milestone payments earned or received				$ 40,000	$ 30,000
Pierre Fabre Commercialization Agreement | Maximum [Member]
License Collaboration And Manufacturing Agreements [Line Items]
Aggregate milestone payments entitle to receive upon achieving certain regulatory and commercial milestones						$ 308,000	550,000		550,000
HCRx Agreement [Member]
License Collaboration And Manufacturing Agreements [Line Items]
Proceeds from sale of future royalties, gross									$ 31,000		$ 31,000
Minimum cash repayment									185.00%
Maximum cash repayment									250.00%
AR Commercialization Agreement [Member]
License Collaboration And Manufacturing Agreements [Line Items]
Additional Upfront Payment Included inTransaction Price							20,000		$ 20,000
Regulatory Milestone		$ 20,000										$ 20,000
Costs Incurred Related to Performance Obligations Included in R&D							$ 4,000	$ 10,300	$ 11,100	$ 22,600